Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Artigo em Inglês | IMSEAR | ID: sea-162126

RESUMO

The third generation biodegradable Drug Eluting Stent (DES) are being evaluated and being introduced in clinical practice. They have been DESigned to overcome limitations associated with durable polymer and a persistent metallic stent scaffold which could be related to late target lesion revascularization (TLR) and very late stent thrombosis (VLST). Although a recent pooled data analysis found that biodegradable polymer stents were superior for TLR and VLST compared with first generation Sirolimus Eluting Stent (SES), superiority has not been demonstrated against second generation Everolimus eluting stents (EES) and is yet to be conclusively proven in randomized trials. This paper reviews the key features, recent trial data, and future directions of the third generation of DES technology including stents with fully biodegradable scaffolds, stents with biodegradable polymer, and polymer free stents.


Assuntos
Implantes Absorvíveis , Plásticos Biodegradáveis , Reestenose Coronária/terapia , Stents Farmacológicos/normas , Stents Farmacológicos/uso terapêutico , Stents Farmacológicos/tendências , Stents Farmacológicos/estatística & dados numéricos , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA